Journey Medical Corporation (NASDAQ: DERM) Stock Information | RedChip

Journey Medical Corporation (NASDAQ: DERM)


$5.5400
+0.3400 ( +7.16% ) 68.4K

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

Market Data


Open


$5.5400

Previous close


$5.2000

Volume


68.4K

Market cap


$113.85M

Day range


$4.9400 - $5.6100

52 week range


$2.8500 - $8.1100

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Jul 10, 2024
4 Insider transactions 1 Jul 10, 2024
4 Insider transactions 1 Jul 10, 2024
4 Insider transactions 1 Jul 10, 2024
8-k 8K-related 14 Jun 25, 2024
4 Insider transactions 1 May 31, 2024
3 Insider transactions 1 May 31, 2024
10-q Quarterly Reports 85 May 14, 2024
8-k 8K-related 15 May 13, 2024
8-k 8K-related 15 May 01, 2024

Latest News